🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate a new questionnaire to capture the...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-10-29
Trial ID
NCT00984659
Treatments Being Tested
The purpose of this study is to demonstrate the pharmacodynamic bioequivale...
Status
Completed
Location
Combined Research Orlando
Start Date
2018-10-17
Trial ID
NCT03394989
First, the investigators will image patients with hyperpolarized xenon (Xe)...
Status
Completed
Location
University of Virginia
Start Date
2016-05-01
Trial ID
NCT02826343
Treatments Being Tested
To compare the efficacy and safety profiles of Fluticasone Propionate 100 m...
Status
Unknown
Location
Multiple Locations
Start Date
2018-10
Trial ID
NCT03562923
Treatments Being Tested
Relatively little information is available about the effects of salmeterol/...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-11
Trial ID
NCT00549146
This is a randomized, placebo-controlled, 2-period crossover, escalating re...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-02-09
Trial ID
NCT02991859
Bioequivalence study between two inhaler products of fixed dose combination...
Status
Completed
Location
BECRO Clinical Facility
Start Date
2018-11-20
Trial ID
NCT03751202
Treatments Being Tested
The purpose of the study is to determine the appropriate dose of fluticason...
Status
Completed
Location
Research Site
Start Date
2006-11
Trial ID
NCT00403286
The purpose of this study is to compare the early onset of effect of Symbic...
Status
Completed
Location
Multiple Locations
Start Date
2003-04
Trial ID
NCT00646620
Treatments Being Tested
This trial is a randomized, double-blind, parallel-group, multicenter study...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-04-30
Trial ID
NCT01110200
Treatments Being Tested